Leukemia Lymphocytic Chronic B-cell
📧 Sign up to get email alerts when something new happens for Leukemia Lymphocytic Chronic B-cell.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-10EMA Authorised: Venclyxto (venetoclax) — AbbVie Deutschland GmbH & Co. KG
EMA confirms authorisation of Venclyxto (venetoclax) for chronic lymphocytic leukemia and related B-cell leukemias; product is authorised fo…
-
EMA approval · 2026-07-06EMA Authorised: Calquence (acalabrutinib;acalabrutinib maleate) — AstraZeneca AB
AstraZeneca's Calquence (acalabrutinib, acalabrutinib maleate) has been authorised by EMA for chronic lymphocytic leukemia and related B-cel…